CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
People›
Jon Resnick
AddedSep 29, 2026
UpdatedSep 29, 2026
Jon Resnick

Jon Resnick

Chief Executive Officer, Certara

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jon Resnick's Career

Certara

Certara

Radnor, PA, US
Chief Executive Officer

Recent news

Certara Launches Marvin Cloud WorldwideCertara · 2026
Certara Reports Second Quarter 2026 Financial ResultsCertara · 2026
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent ToolkitCertara · 2026

Leadership at Certara

Christopher BoutonChristopher BoutonChief Technology Officer
Faiz MohammedFaiz MohammedInterim Chief Financial Officer

Similar to Certara

WeaveWeaveNew York City, NY, USRegulatory DocumentsWeaveNew York City, NY, US

US-based Weave offers an AI collaboration platform for biomedicine.

Series A · $13M7
BluenoteBluenoteSan Francisco, CA, USest. 2022BluenoteSan Francisco, CA, US · est. 2022

Bluenote is an enterprise AI platform for life sciences that automates regulatory and clinical documentation with full source traceability.

Series A · $10M
Veeva SystemsVeeva SystemsPleasanton, CA, USCloud Softwareest. 2007Veeva SystemsPleasanton, CA, US · est. 2007

Veeva Systems: Global cloud software solutions provider

Public6.7k
YseopYseopParis, FRest. 2008YseopParis, FR · est. 2008

Yseop builds regulatory-grade generative AI for medical writing and submission-ready content in life sciences.

IQVIA

IQVIA

Public$1.5BDurham, NC, US
President

Leadership at IQVIA

John DanhaklJohn DanhaklBoard Member
Mireille GillingsMireille GillingsBoard Member
Leonard D. SchaefferLeonard D. SchaefferBoard Member
Ari BousbibAri BousbibBoard Member
John ConnaughtonJohn ConnaughtonBoard Member
Kathy GiustiKathy GiustiBoard Member

Similar to IQVIA

TruvetaTruvetaBellevue, WA, USHealthcare Dataest. 2020TruvetaBellevue, WA, US · est. 2020

Health data company owned by US health systems, licensing de-identified EHR data and evidence services to researchers.

Series C · $515M500
Health CatalystHealth CatalystSalt Lake City, UT, USData Analyticsest. 2008Health CatalystSalt Lake City, UT, US · est. 2008

Health Catalyst: Leading provider of data analytics technology for measurable healthcare improvement.

Public · $440.5M1.2k
ViatrisViatrisCanonsburg, PA, USPharmaceuticalsest. 2020ViatrisCanonsburg, PA, US · est. 2020

Viatris Inc.: A global healthcare company producing pharmaceuticals for a wide range of diseases worldwide.

Public37k
Syneos HealthSyneos HealthMorrisville, NC, USClinical Trials, Drug Developmentest. 1998Syneos HealthMorrisville, NC, US · est. 1998

Syneos Health®: A unique, fully integrated contract research organization for clinical and commercial solutions.

Public · $999.6M29.4k

People Similar to Jon Resnick

Gilles V J PajotGilles V J PajotBoard Member · IQVIAConstantine L ClementeConstantine L ClementeBoard Member · IQVIABrian O'DwyerBrian O'DwyerCEO · IQVIADennis GillingsDennis GillingsFounder · IQVIADavid ComanDavid ComanCEO at Science 37Melissa EasyMelissa EasyFounder · IQVIAJim FasanoJim FasanoBoard Member · IQVIA